Literature DB >> 25124089

Identifying optimal biomarker combinations for treatment selection via a robust kernel method.

Ying Huang1, Youyi Fong.   

Abstract

Treatment-selection markers predict an individual's response to different therapies, thus allowing for the selection of a therapy with the best predicted outcome. A good marker-based treatment-selection rule can significantly impact public health through the reduction of the disease burden in a cost-effective manner. Our goal in this article is to use data from randomized trials to identify optimal linear and nonlinear biomarker combinations for treatment selection that minimize the total burden to the population caused by either the targeted disease or its treatment. We frame this objective into a general problem of minimizing a weighted sum of 0-1 loss and propose a novel penalized minimization method that is based on the difference of convex functions algorithm (DCA). The corresponding estimator of marker combinations has a kernel property that allows flexible modeling of linear and nonlinear marker combinations. We compare the proposed methods with existing methods for optimizing treatment regimens such as the logistic regression model and the weighted support vector machine. Performances of different weight functions are also investigated. The application of the proposed method is illustrated using a real example from an HIV vaccine trial: we search for a combination of Fc receptor genes for recommending vaccination in preventing HIV infection.
© 2014, The International Biometric Society.

Entities:  

Keywords:  Biomarker combination; Kernel method; Randomized trial; Robust; Support vector machine; Treatment selection

Mesh:

Substances:

Year:  2014        PMID: 25124089      PMCID: PMC4277554          DOI: 10.1111/biom.12204

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  16 in total

1.  Dynamic regime marginal structural mean models for estimation of optimal dynamic treatment regimes, Part I: main content.

Authors:  Liliana Orellana; Andrea Rotnitzky; James M Robins
Journal:  Int J Biostat       Date:  2010       Impact factor: 0.968

2.  Generalized genomic distance-based regression methodology for multilocus association analysis.

Authors:  Jennifer Wessel; Nicholas J Schork
Journal:  Am J Hum Genet       Date:  2006-09-21       Impact factor: 11.025

3.  Fuzzy support vector machines.

Authors:  Chun-Fu Lin; Sheng-De Wang
Journal:  IEEE Trans Neural Netw       Date:  2002

4.  Subgroup identification from randomized clinical trial data.

Authors:  Jared C Foster; Jeremy M G Taylor; Stephen J Ruberg
Journal:  Stat Med       Date:  2011-08-04       Impact factor: 2.373

5.  Estimation of treatment policies based on functional predictors.

Authors:  Ian W McKeague; Min Qian
Journal:  Stat Sin       Date:  2014-07       Impact factor: 1.261

6.  Variable selection for optimal treatment decision.

Authors:  Wenbin Lu; Hao Helen Zhang; Donglin Zeng
Journal:  Stat Methods Med Res       Date:  2011-11-23       Impact factor: 3.021

7.  PERFORMANCE GUARANTEES FOR INDIVIDUALIZED TREATMENT RULES.

Authors:  Min Qian; Susan A Murphy
Journal:  Ann Stat       Date:  2011-04-01       Impact factor: 4.028

8.  A robust method for estimating optimal treatment regimes.

Authors:  Baqun Zhang; Anastasios A Tsiatis; Eric B Laber; Marie Davidian
Journal:  Biometrics       Date:  2012-05-02       Impact factor: 2.571

9.  A framework for evaluating markers used to select patient treatment.

Authors:  Holly Janes; Margaret S Pepe; Ying Huang
Journal:  Med Decis Making       Date:  2013-06-27       Impact factor: 2.583

10.  Estimating Optimal Treatment Regimes from a Classification Perspective.

Authors:  Baqun Zhang; Anastasios A Tsiatis; Marie Davidian; Min Zhang; Eric Laber
Journal:  Stat       Date:  2012-01-01
View more
  8 in total

1.  Identification of the optimal treatment regimen in the presence of missing covariates.

Authors:  Ying Huang; Xiao-Hua Zhou
Journal:  Stat Med       Date:  2019-11-27       Impact factor: 2.373

2.  Identifying optimal biomarker combinations for treatment selection through randomized controlled trials.

Authors:  Ying Huang
Journal:  Clin Trials       Date:  2015-05-06       Impact factor: 2.486

3.  Selecting Biomarkers for building optimal treatment selection rules using Kernel Machines.

Authors:  Sayan Dasgupta; Ying Huang
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2019-09-18       Impact factor: 1.864

4.  Estimation and evaluation of linear individualized treatment rules to guarantee performance.

Authors:  Xin Qiu; Donglin Zeng; Yuanjia Wang
Journal:  Biometrics       Date:  2017-09-28       Impact factor: 2.571

5.  Tree-based Ensemble Methods For Individualized Treatment Rules.

Authors:  Kehao Zhu; Ying Huang; Xiao-Hua Zhou
Journal:  Biostat Epidemiol       Date:  2018-03-28

6.  Threshold-based subgroup testing in logistic regression models in two-phase sampling designs.

Authors:  Ying Huang; Juhee Cho; Youyi Fong
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2020-11-28       Impact factor: 1.864

Review 7.  Personalized medicine-concepts, technologies, and applications in inflammatory skin diseases.

Authors:  Thomas Litman
Journal:  APMIS       Date:  2019-05       Impact factor: 3.205

8.  Flexible combination of multiple diagnostic biomarkers to improve diagnostic accuracy.

Authors:  Tu Xu; Yixin Fang; Alan Rong; Junhui Wang
Journal:  BMC Med Res Methodol       Date:  2015-10-31       Impact factor: 4.615

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.